Otsuka Holdings Co., Ltd., founded in 1921 and headquartered in Tokyo, Japan, is a global healthcare company dedicated to the development of innovative pharmaceuticals and nutraceuticals. The company is well-regarded for its diverse portfolio, which includes prescription medications, over-the-counter products, and supplements aimed at enhancing health and well-being.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| OTSUHO 0.26% 2026-03-06 JPYOtsuka Holdings Co.,Ltd. | Japan | 2026-03-06 | 0.260 | 0.26 |
| OTSUHO 0.38% 2029-03-07 JPYOtsuka Holdings Co.,Ltd. | Japan | 2029-03-07 | 0.375 | 1.67 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Otsuka began issuing bonds in the early 2000s as part of its strategy to finance research and development initiatives. Noteworthy issuances include its ¥100 billion bond in 2017, which was aimed at funding new product development, and its recent offerings with yields slightly above industry averages, demonstrating investor confidence. Special features of select bonds include their linkage to sustainable initiatives, reflecting the company's commitment to corporate social responsibility.